How to choose a research peptide supplier

Why supplier selection matters for research quality

Research peptides are complex synthetic molecules. The quality of analytical data generated with them is only as good as the material itself. An impure or misidentified compound does not just waste a reagent budget — it generates misleading data, which can misdirect research programmes for months.

The criteria below are not aspirational — they represent what any supplier providing material for serious research should be able to demonstrate routinely.

Criterion 1

Batch-specific, third-party COA

The most basic quality signal is whether the supplier provides a Certificate of Analysis specific to the batch you are purchasing — not a generic or historical certificate.

Criterion 2

Identity testing by mass spectrometry

HPLC purity alone does not confirm that a compound is what it is stated to be. A high-purity sample could be a closely related analogue, a truncated sequence, or a completely different compound if the chromatographic conditions are insufficiently discriminating.

Mass spectrometry — either ESI-MS or MALDI-ToF — is the minimum identity test. It confirms molecular weight, which for peptides is highly sequence-specific. A supplier who does not include MS data on their COA cannot confirm identity.

Criterion 3

Endotoxin testing for cell-based work

Bacterial endotoxins (lipopolysaccharides, LPS) are a routine contaminant of peptides synthesised using standard solid-phase methods. Even sub-nanogram per millilitre concentrations of LPS activate Toll-like receptor 4 (TLR4) signalling in mammalian cells, causing cytokine release, NF-κB activation, and other inflammatory responses that can completely confound in-vitro results.

The Limulus Amebocyte Lysate (LAL) assay — or its recombinant equivalent (rFC assay) — is the reference method for endotoxin detection per USP ⟨85⟩ and Ph. Eur. 2.6.14. For research peptides, a specification of ≤ 5 EU/mg is common, though cell-based assay work may require tighter limits.

Criterion 4

Cold-chain handling and packaging

Lyophilised peptides are generally stable at ambient temperature for shipping if protected from moisture and light. However, some peptides — particularly those containing oxidation-sensitive residues (Met, Cys, Trp) or stored in solution — require refrigerated or frozen transport.

Criterion 5

Residual solvents and heavy metals

Standard solid-phase peptide synthesis (SPPS) uses organic solvents — typically DMF (dimethylformamide), DCM (dichloromethane), and acetonitrile — as well as TFA (trifluoroacetic acid) for deprotection and cleavage. Inadequate lyophilisation or post-synthesis workup can leave residual solvents in the final product.

ICH Q3C classifies solvents by toxicity: Class 1 (to be avoided), Class 2 (limited by PDE), Class 3 (low toxicity, limit ≤ 50 mg/day). DMF is a Class 2 solvent with a PDE of 8.8 mg/day. Residual solvent testing by headspace GC-FID or GC-MS is the standard method per USP ⟨467⟩.

Heavy metals (particularly palladium from Pd-catalysed coupling reactions, if used) should also be monitored per ICH Q3D guidelines for materials that will be used at high doses in biological systems.